BIOMAT Database Logo BIOMAT Database Logo

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. 1989

S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Oncology Center, Johns Hopkins University School of Medicine, Baltimore, MD 21231.

Previous studies have demonstrated that allelic deletions of the short arm of chromosome 17 occur in over 75% of colorectal carcinomas. Twenty chromosome 17p markers were used to localize the common region of deletion in these tumors to a region contained within bands 17p12 to 17p13.3. This region contains the gene for the transformation-associated protein p53. Southern and Northern blot hybridization experiments provided no evidence for gross alterations of the p53 gene or surrounding sequences. As a more rigorous test of the possibility that p53 was a target of the deletions, the p53 coding regions from two tumors were analyzed; these two tumors, like most colorectal carcinomas, had allelic deletions of chromosome 17p and expressed considerable amounts of p53 messenger RNA from the remaining allele. The remaining p53 allele was mutated in both tumors, with an alanine substituted for valine at codon 143 of one tumor and a histidine substituted for arginine at codon 175 of the second tumor. Both mutations occurred in a highly conserved region of the p53 gene that was previously found to be mutated in murine p53 oncogenes. The data suggest that p53 gene mutations may be involved in colorectal neoplasia, perhaps through inactivation of a tumor suppressor function of the wild-type p53 gene.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009693 Nucleic Acid Hybridization Widely used technique which exploits the ability of complementary sequences in single-stranded DNAs or RNAs to pair with each other to form a double helix. Hybridization can take place between two complimentary DNA sequences, between a single-stranded DNA and a complementary RNA, or between two RNA sequences. The technique is used to detect and isolate specific sequences, measure homology, or define other characteristics of one or both strands. (Kendrew, Encyclopedia of Molecular Biology, 1994, p503) Genomic Hybridization,Acid Hybridization, Nucleic,Acid Hybridizations, Nucleic,Genomic Hybridizations,Hybridization, Genomic,Hybridization, Nucleic Acid,Hybridizations, Genomic,Hybridizations, Nucleic Acid,Nucleic Acid Hybridizations
D009857 Oncogenes Genes whose gain-of-function alterations lead to NEOPLASTIC CELL TRANSFORMATION. They include, for example, genes for activators or stimulators of CELL PROLIFERATION such as growth factors, growth factor receptors, protein kinases, signal transducers, nuclear phosphoproteins, and transcription factors. A prefix of "v-" before oncogene symbols indicates oncogenes captured and transmitted by RETROVIRUSES; the prefix "c-" before the gene symbol of an oncogene indicates it is the cellular homolog (PROTO-ONCOGENES) of a v-oncogene. Transforming Genes,Oncogene,Transforming Gene,Gene, Transforming,Genes, Transforming
D010750 Phosphoproteins Phosphoprotein
D002872 Chromosome Deletion Actual loss of portion of a chromosome. Monosomy, Partial,Partial Monosomy,Deletion, Chromosome,Deletions, Chromosome,Monosomies, Partial,Partial Monosomies
D002886 Chromosomes, Human, Pair 17 A specific pair of GROUP E CHROMOSOMES of the human chromosome classification. Chromosome 17
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph

Related Publications

S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
January 2004, Oncology reports,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Allelic deletions on chromosome-17 and mutations in the p53 gene in tumors metastatic to brain.
January 1994, International journal of oncology,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas.
March 1995, Annals of the Academy of Medicine, Singapore,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
July 1993, Cancer research,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
P53 gene mutations in pituitary carcinomas.
January 2007, Endocrine pathology,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
January 1994, Anticancer research,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17.
August 1995, Annals of hematology,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
September 2001, International journal of oncology,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Importance of cytogenetic markers for multiple primary carcinomas in colorectal cancer: chromosome 17 and p53 locus translocation.
October 1998, Journal of gastroenterology,
S J Baker, and E R Fearon, and J M Nigro, and S R Hamilton, and A C Preisinger, and J M Jessup, and P vanTuinen, and D H Ledbetter, and D F Barker, and Y Nakamura, and R White, and B Vogelstein
Discordance of p53 mutations of synchronous colorectal carcinomas.
February 2000, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Copied contents to your clipboard!